Community Trust Bancorp Inc
Change company Symbol lookup
Select an option...
CTBI Community Trust Bancorp Inc
$NYLGCAPT NYSE U.S. Large Cap Equal Weight Ind
VIVC Vivic Corp
BAC Bank of America Corp
DGRW WisdomTree U.S. Quality Dividend Growth Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DFP Flaherty & Crumrine Dynamic Preferred and Income Fund
DES WisdomTree U.S. SmallCap Dividend Fund
DEO Diageo PLC
DDF Delaware Investments Dividend and Income Fund
Go

Financials : Banks | Small Cap Blend
Company profile

Community Trust Bancorp, Inc. is a bank holding company. The Company holds interests in a commercial bank, Community Trust Bank, Inc. (the Bank), and a trust company, Community Trust and Investment Company. Through its subsidiaries, the Company engages in a range of commercial and personal banking, and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes, and providing funds transfer services. Its loan portfolio includes commercial loans, such as construction loans, loans secured by real estate, equipment lease financing and commercial other loans; residential loans, such as real estate construction loans, real estate mortgages and home equity loans, and consumer loans, such as consumer direct loans and consumer indirect loans.

Closing Price
$31.57
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
63,569
0

Federman & Sherwood Investigates CytoDyn Inc. for Possible Violations of Federal Securities Laws

11:33 am ET May 8, 2020 (BusinessWire) Print

The law firm of Federman & Sherwood has initiated an investigation into CytoDyn Inc. (OTC: CYDY) and its officers and directors, with respect to possible violations of federal securities laws. On April 27, 2020, CytoDyn, a late-stage biotechnology company, issued a press release indicating it had submitted a "Biologics License Application ("BLA") to the U.S. Food and Drug Administration for Leronlimab as a combination therapy with HAART for highly treatment experienced HIV patients." On May 7, 2020, CytoDyn announced that its BLA for Leronlimab "will be considered completed after the clinical datasets are submitted on May 11, 2020."

If you purchased shares of common stock and suffered a loss on that investment in CytoDyn Inc., and would like to learn more about the investigation, please visit: https://www.federmanlaw.com/blog/federman-sherwood-investigates-cytodyn-inc-for-possible-violations-of-federal-securities-laws/

If you have any information to assist in our investigation or have questions or concerns regarding this notice or your rights or interests in this matter, or you may contact William B. Federman at (405) 235-1560 or by email at wbf@federmanlaw.com with any questions you may have regarding this investigation. Federman & Sherwood has extensive nationwide experience in representing investors in securities, derivative and merger-related shareholder class actions, and has been appointed as lead counsel in multiple complex cases across the country.

Robin Hester FEDERMAN & SHERWOOD 10205 North Pennsylvania Avenue Oklahoma City, OK 73120 (405) 235-1560 Email any Inquiries to: rkh@federmanlaw.com or visit our website at www.federmanlaw.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20200508005364/en/

SOURCE: Federman & Sherwood">

Robin Hester
FEDERMAN & SHERWOOD
(405) 235-1560
rkh@federmanlaw.com 
www.federmanlaw.com

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.